Racial difference in cardiovascular outcomes following percutaneous coronary intervention in a public health service

Sirikarn Napan1, Ramesh Kashinath, Maria Orig

  • 1Division of Cardiology, Department of Medicine, John H Stroger, Jr Hospital of Cook County, Chicago, Illinois, USA. snapan@howard.edu

Insights

Black patients experienced significantly higher rates of major adverse cardiac events (MACE) and death after percutaneous coronary intervention (PCI). These disparities persisted even after adjusting for risk factors, highlighting a critical area for cardiovascular health equity.

Area of Science:

  • Cardiovascular Medicine
  • Health Disparities Research
  • Interventional Cardiology

Background:

  • Conflicting data exists on racial disparities in long-term cardiovascular outcomes post-percutaneous coronary intervention (PCI).
  • Investigating these disparities in a Public Health Service (PHS) setting is crucial for understanding population health trends.

Purpose of the Study:

  • To compare major adverse cardiac events (MACE) following PCI in Black versus non-Black patients.
  • To identify if race is an independent predictor of cardiovascular outcomes after PCI.

Main Methods:

  • A cohort of 1,438 patients undergoing PCI between 2002 and 2006 was analyzed.
  • Major adverse cardiac events (MACE) were defined as death, myocardial infarction (MI), or urgent target vessel revascularization.
  • Follow-up was conducted for a mean of 2.9 years.

Main Results:

  • Black patients (47.4%) had a significantly higher MACE rate (21.7%) compared to non-Black patients (13.6%).
  • Black race remained an independent predictor of MACE (adjusted HR, 1.52; CI, 1.18-1.96), with higher rates of death and MI.
  • No racial differences were observed in in-hospital mortality or MACE at 3 and 6 months.

Conclusions:

  • Black individuals experienced worse long-term cardiovascular outcomes and mortality after PCI in this PHS population.
  • These disparities were evident irrespective of baseline cardiovascular risk factors, socioeconomic status, or healthcare access.
  • Findings underscore the need for targeted interventions to address racial inequities in cardiovascular care post-PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...